Inventor · disambiguated record
Samuel Mok
Also filed as: MOK SAMUEL · MOK SAMUEL C
4 granted patents·6 pending applications·29 citations·filing 2001–2020
73Inventor score
Files withBRIGHAM & WOMENS HOSPITAL4BIRRER MICHAEL J2BATTELLE MEMORIAL INSTITUTE1METHODIST HOSPITAL1
Top patents by PatentIndex Score
10 records- 0171US7112408B2Detection of ovarian cancer based upon alpha-haptoglobin levelsBRIGHAM & WOMENS HOSPITAL·Filed 2002·Granted Sep 26, 2006·14 cites·18 claims
- 0269US6846642B2Methods of detecting cancer based on prostasinBRIGHAM & WOMENS HOSPITAL·Filed 2001·Granted Jan 25, 2005·9 cites·8 claims
- 0363US7288383B2Eosinophil-derived neurotoxin as a marker for ovarian cancerBRIGHAM & WOMENS HOSPITAL·Filed 2004·Granted Oct 30, 2007·6 cites·5 claims
- 0450US7214501B2Methods of detecting cancer based on osteopontinBATTELLE MEMORIAL INSTITUTE·Filed 2004·Granted May 8, 2007·0 cites·5 claims
- 0547US2024199735A1Microfibrillar-Associated Protein 5 (MFAP5)-Targeting Monoclonal Antibodies and Methods for Use in Treating CancerMETHODIST HOSPITAL·Filed 2020·Application pending·0 cites
- 0644US2005009120A1Methods of detecting ovarian cancer based on osteopontinBRIGHAM & WOMENS HOSPITAL·Filed 2004·Application pending·0 cites
- 0737US2002156039A1Diagnosing and treating cancer cells using Sal2Filed 2001·Application pending·0 cites
- 0836US2002147996A1Diagnosing and treating cancer cells using Sal2Filed 2001·Application pending·0 cites
- 0932US2010292303A1Gene expression profile for predicting ovarian cancer patient survivalBIRRER MICHAEL J·Filed 2008·Application pending·0 cites
- 1032US2011178154A1gene expression profile that predicts ovarian cancer subject response to chemotherapyBIRRER MICHAEL J·Filed 2008·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →